Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Artificial Urinary Sphincter Cuff Size Predicts Outcome in Male Patients Treated for Stress Incontinence: Results of a Large Central European Multicenter Cohort Study.

Queissert F, Huesch T, Kretschmer A, Anding R, Kurosch M, Kirschner-Hermanns R, Pottek T, Olianas R, Friedl A, Pfitzenmaier J, Naumann CM, Wotzka C, Nyarangi-Dix J, Hoffmann T, Herrmann E, Obaje A, Rose A, Homberg R, Abdunnur R, Loertzer H, Bauer RM, Haferkamp A, Schrader AJ.

Int Neurourol J. 2019 Sep;23(3):219-225. doi: 10.5213/inj.1938032.016. Epub 2019 Sep 30.

2.

Benefits and Complications during the Stay at an Early Rehabilitation Facility after Radical Cystectomy and Orthotopic Ileum Neobladder Reconstruction.

Schulz GB, Grimm T, Buchner A, Kretschmer A, Stief CG, Karl A, Jokisch F.

Urol Int. 2019;103(3):350-356. doi: 10.1159/000502657. Epub 2019 Sep 5.

PMID:
31487741
3.

Robotic-assisted Excision of Giant Prostatic Utricular Cysts: Technique, Outcomes and Follow-up.

Khoder WY, Gratzke C, Kretschmer A, Becker A, Stief C.

Surg Technol Int. 2019 Aug 1;35. pii: sti35/1165. [Epub ahead of print]

PMID:
31373378
4.

Extended follow-up of the AdVance XP male sling in the treatment of male urinary stress incontinence after 48 months: Results of a prospective and multicenter study.

Grabbert M, Mumm JN, Klehr B, Kretschmer A, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Bauer RM.

Neurourol Urodyn. 2019 Sep;38(7):1973-1978. doi: 10.1002/nau.24101. Epub 2019 Jul 11.

PMID:
31297894
5.

Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist.

Kolkhof P, Pook E, Pavkovic M, Kretschmer A, Buchmüller A, Tinel H, Delbeck M, Mondritzki T, Wasnaire P, Dinh W, Truebel H, Hüser J, Schmeck C.

J Cardiovasc Pharmacol. 2019 Jul;74(1):44-52. doi: 10.1097/FJC.0000000000000677.

PMID:
31274842
6.

CAR-Expressing Natural Killer Cells for Cancer Retargeting.

Kloess S, Kretschmer A, Stahl L, Fricke S, Koehl U.

Transfus Med Hemother. 2019 Feb;46(1):4-13. doi: 10.1159/000495771. Epub 2019 Feb 5. Review.

7.

Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.

Jokisch JF, Grimm T, Buchner A, Kretschmer A, Weinhold P, Stief CG, Karl A, Schulz GB.

Urol Int. 2019 Jun 26:1-6. doi: 10.1159/000500729. [Epub ahead of print]

PMID:
31242481
8.

Stress-induced tunneling nanotubes support treatment adaptation in prostate cancer.

Kretschmer A, Zhang F, Somasekharan SP, Tse C, Leachman L, Gleave A, Li B, Asmaro I, Huang T, Kotula L, Sorensen PH, Gleave ME.

Sci Rep. 2019 May 24;9(1):7826. doi: 10.1038/s41598-019-44346-5.

9.
10.

[Influence of modern diagnostic methods on the treatment of nonmetastatic castration-resistant prostate cancer].

Kretschmer A, Tilki D.

Urologe A. 2019 May;58(5):529-534. doi: 10.1007/s00120-019-0904-7. Review. German.

PMID:
30887058
11.

Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?

Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Gandaglia G, Briganti A, de Visschere P, Mathieu R, Valerio M, van den Bergh R, Ost P, Mirvald C, Tilki D, Ploussard G, Surcel C; EAU-YAU Prostate Cancer Working Party.

Cancer Treat Rev. 2019 May;75:20-26. doi: 10.1016/j.ctrv.2019.03.001. Epub 2019 Mar 11. Review.

PMID:
30875581
12.

[Current controversies in the treatment of localized prostate cancer].

Bischoff R, Chaloupka M, Westhofen T, Grimm T, Schlenker B, Weinhold P, Tilki D, Stief CG, Kretschmer A.

Urologe A. 2019 May;58(5):524-528. doi: 10.1007/s00120-019-0903-8. Review. German.

PMID:
30859231
13.

Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.

Kretschmer A, Grimm T, Buchner A, Jokisch F, Ziegelmüller B, Casuscelli J, Schulz G, Stief CG, Karl A.

Eur Urol Focus. 2019 Mar 7. pii: S2405-4569(19)30052-5. doi: 10.1016/j.euf.2019.02.017. [Epub ahead of print]

PMID:
30853603
14.

[Active surveillance of prostate cancer : An update].

Chaloupka M, Westhofen T, Kretschmer A, Grimm T, Stief C, Apfelbeck M.

Urologe A. 2019 Mar;58(3):329-340. doi: 10.1007/s00120-019-0894-5. German.

PMID:
30824971
15.

[Management of ureteral injuries].

Ledderose S, Beck V, Chaloupka M, Kretschmer A, Strittmatter F, Tritschler S.

Urologe A. 2019 Feb;58(2):197-206. doi: 10.1007/s00120-019-0864-y. German.

PMID:
30734059
16.

Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes.

Grimm T, Grimm J, Buchner A, Schulz G, Jokisch F, Stief CG, Karl A, Kretschmer A.

World J Urol. 2019 Jan 30. doi: 10.1007/s00345-019-02643-8. [Epub ahead of print]

PMID:
30701335
17.

Assessing the level of radiation experienced by anesthesiologists during transfemoral Transcatheter Aortic Valve Implantation and protection by a lead cap.

Mayr NP, Wiesner G, Kretschmer A, Brönner J, Hoedlmoser H, Husser O, Kasel AM, Lange R, Tassani-Prell P.

PLoS One. 2019 Jan 30;14(1):e0210872. doi: 10.1371/journal.pone.0210872. eCollection 2019.

18.

Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE).

Kretschmer A, Gleave ME.

Eur Urol. 2019 Apr;75(4):692-693. doi: 10.1016/j.eururo.2018.12.035. Epub 2019 Jan 5. No abstract available.

PMID:
30616949
19.

Are There Still Patients with Metastatic Hormone-sensitive Prostate Cancer Who Should Be Treated with Androgen Deprivation Monotherapy?

Kretschmer A, Todenhöfer T.

Eur Urol Focus. 2019 Mar;5(2):114-116. doi: 10.1016/j.euf.2018.11.008. Epub 2018 Nov 24.

PMID:
30482584
20.

Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia.

Hilger N, Mueller C, Stahl L, Mueller AM, Zoennchen B, Dluczek S, Halbich C, Wickenhauser C, Gerloff D, Wurm AA, Behre G, Kretschmer A, Fricke S.

Front Immunol. 2018 Oct 22;9:2408. doi: 10.3389/fimmu.2018.02408. eCollection 2018.

21.

Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.

Ploussard G, Gandaglia G, Borgmann H, de Visschere P, Heidegger I, Kretschmer A, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, Ost P, Briganti A; EAU-YAU Prostate Cancer Working Group.

Eur Urol. 2019 Oct;76(4):493-504. doi: 10.1016/j.eururo.2018.10.041. Epub 2018 Oct 31. Review.

PMID:
30391078
22.

Comparison of adjustable male slings and artificial urinary sphincter in the treatment of male urinary incontinence: a retrospective analysis of patient selection and postoperative continence status.

Grabbert M, Hüsch T, Kretschmer A, Kirschner-Hermanns R, Anding R, Rose A, Friedl A, Obaje A, Heidenreich A, Brehmer B, Naumann CM, Queissert F, Loertzer H, Pfitzenmaier J, Nyarangi-Dix J, Kurosch M, Olianas R, Homberg R, Abdunnur R, Schweiger J, Hofmann T, Wotzka C, Pottek T, Huebner W, Haferkamp A, Bauer RM.

World J Urol. 2019 Jul;37(7):1415-1420. doi: 10.1007/s00345-018-2523-0. Epub 2018 Oct 19.

PMID:
30341450
23.

Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey.

Marra G, Ploussard G, Ost P, De Visschere PJL, Briganti A, Gandaglia G, Tilki D, Surcel CI, Tsaur I, Van Den Bergh RCN, Kretschmer A, Borgmann H, Gontero P, Ahmed HU, Valerio M; EAU-YAU Prostate Cancer Working Party.

Urol Oncol. 2018 Dec;36(12):529.e11-529.e22. doi: 10.1016/j.urolonc.2018.08.013. Epub 2018 Oct 6.

PMID:
30301698
24.

Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary update.

Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Mirvald C, Gandaglia G, Briganti A, van den Bergh R, Tilki D, Ost P, Ploussard G, Surcel C; EAU-YAU Prostate Cancer Working Party.

Urol Oncol. 2018 Nov;36(11):488-497. doi: 10.1016/j.urolonc.2018.08.016. Epub 2018 Sep 27. Review.

PMID:
30268712
25.

Validation of a High-End Virtual Reality Simulator for Training Transurethral Resection of Bladder Tumors.

Schulz GB, Grimm T, Buchner A, Jokisch F, Casuscelli J, Kretschmer A, Mumm JN, Ziegelmüller B, Stief CG, Karl A.

J Surg Educ. 2019 Mar - Apr;76(2):568-577. doi: 10.1016/j.jsurg.2018.08.001. Epub 2018 Sep 1.

PMID:
30181038
26.

Surgical High-risk Patients With ASA ≥ 3 Undergoing Radical Cystectomy: Morbidity, Mortality, and Predictors for Major Complications in a High-volume Tertiary Center.

Schulz GB, Grimm T, Buchner A, Jokisch F, Kretschmer A, Casuscelli J, Ziegelmüller B, Stief CG, Karl A.

Clin Genitourin Cancer. 2018 Dec;16(6):e1141-e1149. doi: 10.1016/j.clgc.2018.07.022. Epub 2018 Aug 1.

PMID:
30174234
27.

[Therapeutic options for stress urinary incontinence following surgery for benign prostate enlargement].

Kretschmer A, Gratzke C.

Aktuelle Urol. 2018 Aug;49(4):334-338. doi: 10.1055/a-0642-1701. Epub 2018 Aug 7. Review. German.

PMID:
30086591
28.

Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) mice.

Walcher L, Müller C, Hilger N, Kretschmer A, Stahl L, Wigge S, Rengelshausen J, Müller AM, Fricke S.

Exp Anim. 2019 Feb 26;68(1):1-11. doi: 10.1538/expanim.18-0056. Epub 2018 Aug 3.

29.

Imaging modalities in synchronous oligometastatic prostate cancer.

Futterer JJ, Surcel C, van den Bergh R, Borgmann H, Briganti A, Gandaglia G, Kretschmer A, Ost P, Sooriakumaran P, Tilki D, Valerio M, Ploussard G, De Visschere PJL, Tsaur I; EAU-YAU Prostate Cancer Working Party.

World J Urol. 2018 Aug 1. doi: 10.1007/s00345-018-2416-2. [Epub ahead of print]

PMID:
30069582
30.

Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?

Ploussard G, Borgmann H, Briganti A, de Visschere P, Fütterer JJ, Gandaglia G, Heidegger I, Kretschmer A, Mathieu R, Ost P, Sooriakumaran P, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R; EAU-YAU Prostate Cancer Working Group.

World J Urol. 2019 Feb;37(2):243-251. doi: 10.1007/s00345-018-2399-z. Epub 2018 Jul 2. Review.

PMID:
29967944
31.

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G; European Association of Urology Young Academic Urologists Working Party on Prostate Cancer (EAU-YAUWP).

BJU Int. 2018 Nov;122(5):823-830. doi: 10.1111/bju.14391. Epub 2018 Jun 3.

PMID:
29772103
32.

The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?

Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Kirschner-Hermanns R, Pottek T, Rose A, Olianas R, Lusuardi L, Friedl A, Homberg R, Pfitzenmaier J, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Brehmer B, Abdunnur R, Loertzer H, Ulm K, Hübner W, Bauer RM, Haferkamp A.

World J Urol. 2018 Oct;36(10):1657-1662. doi: 10.1007/s00345-018-2316-5. Epub 2018 May 4.

PMID:
29728764
33.

Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.

Chaykovska L, Heunisch F, von Einem G, Hocher CF, Tsuprykov O, Pavkovic M, Sandner P, Kretschmer A, Chu C, Elitok S, Stasch JP, Hocher B.

PLoS One. 2018 Apr 12;13(4):e0195828. doi: 10.1371/journal.pone.0195828. eCollection 2018.

34.

Local treatment for metastatic prostate cancer: A systematic review.

Tilki D, Pompe RS, Bandini M, Marchioni M, Kretschmer A, Tian Z, Karakiewicz PI, Evans CP.

Int J Urol. 2018 May;25(5):390-403. doi: 10.1111/iju.13535. Epub 2018 Mar 23.

35.

Long-term functional outcome analysis in a large cohort of patients after radical prostatectomy.

Grabbert M, Buchner A, Butler-Ransohoff C, Kretschmer A, Stief CG, Bauer RM.

Neurourol Urodyn. 2018 Sep;37(7):2263-2270. doi: 10.1002/nau.23557. Epub 2018 Mar 22.

PMID:
29566265
36.

New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies.

Meyer S, Evers M, Jansen JHM, Buijs J, Broek B, Reitsma SE, Moerer P, Amini M, Kretschmer A, Ten Broeke T, den Hartog MT, Rijke M, Klein C, Valerius T, Boross P, Leusen JHW.

Br J Haematol. 2018 Mar;180(6):808-820. doi: 10.1111/bjh.15132. Epub 2018 Feb 22.

PMID:
29468712
37.

Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction.

Wilck N, Markó L, Balogh A, Kräker K, Herse F, Bartolomaeus H, Szijártó IA, Gollasch M, Reichhart N, Strauss O, Heuser A, Brockschnieder D, Kretschmer A, Lesche R, Sohler F, Stasch JP, Sandner P, Luft FC, Müller DN, Dechend R, Haase N.

JCI Insight. 2018 Feb 22;3(4). pii: 96006. doi: 10.1172/jci.insight.96006. eCollection 2018 Feb 22.

38.

[Conservative treatment options for female incontinence].

Kretschmer A, Bauer RM.

Aktuelle Urol. 2018 Feb;49(1):73-77. doi: 10.1055/s-0043-121483. Epub 2017 Dec 21. Review. German.

PMID:
29270930
39.

Male Incontinence: The Etiology or Basis of Treatment.

Hester AG, Kretschmer A, Badlani G.

Eur Urol Focus. 2017 Oct;3(4-5):377-384. doi: 10.1016/j.euf.2017.12.002. Epub 2017 Dec 15. Review.

PMID:
29249687
40.

[Stricture of the vesicourethral anastomosis after radical prostatectomy].

Beck V, Apfelbeck M, Chaloupka M, Kretschmer A, Strittmatter F, Tritschler S.

Urologe A. 2018 Jan;57(1):29-33. doi: 10.1007/s00120-017-0550-x. Review. German.

PMID:
29209754
41.

Biomarkers in prostate cancer - Current clinical utility and future perspectives.

Kretschmer A, Tilki D.

Crit Rev Oncol Hematol. 2017 Dec;120:180-193. doi: 10.1016/j.critrevonc.2017.11.007. Epub 2017 Nov 13. Review.

PMID:
29198331
42.

[Diagnostic workup of urethral strictures].

Chaloupka M, Beck V, Kretschmer A, Tritschler S, Stief CG, Strittmatter F.

Urologe A. 2018 Jan;57(1):6-10. doi: 10.1007/s00120-017-0547-5. Review. German.

PMID:
29189873
43.

Surgical Treatment of Male Postprostatectomy Incontinence: Current Concepts.

Kretschmer A, Nitti V.

Eur Urol Focus. 2017 Oct;3(4-5):364-376. doi: 10.1016/j.euf.2017.11.007. Epub 2017 Nov 23. Review.

PMID:
29174616
44.

Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients.

Herlemann A, Kretschmer A, Buchner A, Karl A, Tritschler S, El-Malazi L, Fendler WP, Wenter V, Ilhan H, Bartenstein P, Stief CG, Gratzke C.

Oncotarget. 2017 Sep 21;8(48):84180-84192. doi: 10.18632/oncotarget.21118. eCollection 2017 Oct 13.

45.

[Male urinary incontinence - causes and therapeutic approaches for male stress incontinence].

Grabbert MT, Kretschmer A, Stief C, Bauer R.

MMW Fortschr Med. 2017 Nov;159(19):52-56. doi: 10.1007/s15006-017-0278-y. Review. German. No abstract available.

PMID:
29124582
46.

Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives.

Hertel J, König J, Homuth G, Van der Auwera S, Wittfeld K, Pietzner M, Kacprowski T, Pfeiffer L, Kretschmer A, Waldenberger M, Kastenmüller G, Artati A, Suhre K, Adamski J, Langner S, Völker U, Völzke H, Nauck M, Friedrich N, Grabe HJ.

Sci Rep. 2017 Oct 26;7(1):14111. doi: 10.1038/s41598-017-13927-7.

47.

Antibody Isotypes for Tumor Immunotherapy.

Kretschmer A, Schwanbeck R, Valerius T, Rösner T.

Transfus Med Hemother. 2017 Sep;44(5):320-326. doi: 10.1159/000479240. Epub 2017 Sep 7. Review.

48.

An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.

Wirt T, Rosskopf S, Rösner T, Eichholz KM, Kahrs A, Lutz S, Kretschmer A, Valerius T, Klausz K, Otte A, Gramatzki M, Peipp M, Kellner C.

Transfus Med Hemother. 2017 Sep;44(5):292-300. doi: 10.1159/000479978. Epub 2017 Sep 11.

49.

The TiLOOP® Male Sling: Did We Forejudge.

Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Kirschner-Hermanns R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Brehmer B, Ulm K, Bauer RM, Haferkamp A; Debates On Male Incontinence (DOMINO)-Project 8.

Urol Int. 2018;100(2):216-221. doi: 10.1159/000477765. Epub 2017 Oct 26.

PMID:
29069660
50.

The dynamics of smoking-related disturbed methylation: a two time-point study of methylation change in smokers, non-smokers and former smokers.

Wilson R, Wahl S, Pfeiffer L, Ward-Caviness CK, Kunze S, Kretschmer A, Reischl E, Peters A, Gieger C, Waldenberger M.

BMC Genomics. 2017 Oct 18;18(1):805. doi: 10.1186/s12864-017-4198-0.

Supplemental Content

Loading ...
Support Center